SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
297Per my commentary over on Trickle about the Eos/PCOP tie-up, the description of tuck-12/21/2001
296Guess that solves their immediate cash problems, and a bit more besides... I wisnigel bates-12/20/2001
295MorphoSys and Schering Form Strategic Alliance to Develop Therapeutic and DiagnoIcebrg-12/20/2001
294Nigel, (edited once I noticed you posted the PR already) One thing I didn'tuck-12/18/2001
293Genentech Granted Fundamental U.S. Patent for Antibody Technology SOUTH SAN FRANkeokalani'nui-12/18/2001
292AVANIR Subsidiary Xenerex Biosciences Advances to Second Stage of Antibody Agreenigel bates-12/18/2001
291Don't forget the apostrophe's what ? <g>nigel bates-12/12/2001
290And please don't forget the apostrophe's.tom pope-12/12/2001
289I'm off to the States for Christmas. Relying on you, Ice, to keep the Europenigel bates-12/12/2001
288Genmab's HuMax-CD4 to Enter Phase III Studies in Arthritis FDA Gives PermissIcebrg-12/12/2001
287XTL Biopharmaceuticals Announces Positive Interim Phase IIa Results In Chronic Hnigel bates-12/10/2001
286IMPROVING THE EFFICACY OF ANTIBODY-BASED CANCER THERAPIES (From Nature reviewsIcebrg-12/8/2001
285Nobody laugh, OK? I am getting uncomfortable with business models that rely on keokalani'nui-12/5/2001
284Parking contd... NEWS RELEASE Oslo, October 1st. 2001 AFFITECH AND ISOGENICA Anigel bates-12/5/2001
283Parking - affitech.com The antibodies selected from Affitech's libraries arnigel bates-12/5/2001
282I said "license". I was talking about the subsequent deal, and I'scaram(o)uche-12/4/2001
281The ImmGenics deal was considered to be worth abt. 77 mUSD (110 mCAD) in a stockIcebrg-12/4/2001
280Despite what you've heard, it's not like deriving mouse monoclonals fromscaram(o)uche-12/4/2001
279<i>Consider, for example, the possibility that the XenoMouse has been overnigel bates-12/4/2001
278>> Any scientists out there who can tell us how significant this is ? <scaram(o)uche-12/4/2001
277Any scientists out there who can tell us how significant this is ? Abgenix Intrnigel bates-12/4/2001
276Abgenix pipeline summary Message 16725708 IceIcebrg-11/30/2001
275Boehringer Ingelheim and ImmunoGen Sign Exclusive License Agreement New ProductIcebrg-11/28/2001
274MorphoSys Unveils New Antibody Library MARTINSRIED, Munich, Germany, Nov. 28 /Pnigel bates-11/28/2001
273<i>I didn't really want to run a profitable company</i> Plenty nigel bates-11/27/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News